Bentham Science Logo

Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued)

Volume 2, 2 Issues, 2015
ISSN: 2212-7046 (Online)
ISSN: 2212-7038 (Print)
This journal supports open access

Aims & Scope

Clinical Anti-Inflammatory & Anti-Allergy Drugs publishes original research, expert reviews, drug clinical trials and thematic issues in all core areas of translational and clinical anti-inflammatory & anti-allergy drug research.

The journal publishes pre-clinical and clinical studies on the development of new anti-inflammatory & anti-allergy agents. Clinical studies of new reported anti-inflammatory & anti-allergy drugs include Phase 1 – IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinicians, toxicologists, medicinal chemists, and to pharmacologists.

Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued)


Volume 2


Number 1


Systemic Application of Anti-inflammatory Agents in Periodontal Treatment

, 2(1): 3 - 13

Kevimy Agossa, David-Nicolas Morand, Henri Tenenbaum, Jean-Luc Davideau and Olivier Huck

DOI: 10.2174/221270380201160517185229

Articles Ahead of Print

There are currently no Articles Ahead of Print available for this journal.

Abstracts Ahead of Print

There are currently no Abstracts Ahead of Print available for this journal.

Editor's Choice

Open Access Articles

Most Cited Articles

Most Accessed Articles

Quilizumab is an Afucosylated Humanized Anti-M1 Prime Therapeutic Antibody

, 2014; 1(1): 24-31.

Hans D. Brightbill, Yuwen L. Lin, Zhonghua Lin, Martha Tan, Y. Gloria Meng, Mercedesz Balazs, Shan Chung and Lawren C. Wu

DOI: 10.2174/22127038114019990003

Therapeutic Targeting of Type 2 Inflammation for the Treatment of Severe Asthma

, 2014; 1(1): 2-10.

Lawren C. Wu, Joseph R. Arron, Jeffrey M. Harris, John G. Matthews and Karin Rosen

DOI: 10.2174/2212703801999131206110837

Activin-A: A New Piece in the Puzzle of Tolerance in Asthma

, 2014; 1(1): 45-56.

Sofia Tousa, Maria Semitekolou, Ioannis Morianos, Aikaterini I Trochoutsou and Georgina Xanthou

DOI: 10.2174/2212703801666140221004020

In Vitro Analysis of Proliferating CD4+ T Cells in Patients with Rheumatoid Arthritis as a Possible Predictable Marker of TNF-alpha Blockers

, 2014; 1(1): 32-38.

Syuichi Koarada, Yuri Sadanaga, Natsumi Nagao, Satoko Tashiro, Rie Suematsu, Akihide Ohta and Yoshifumi Tada

DOI: 10.2174/22127038114016660004


Giovanni Passalacqua
Department of Internal Medicine, Allergy & Respiratory Diseases
University of Genova
View Full Editorial Board

Related Journals

Related eBooks

eBooks Catalog